Repository Universitas Muhammadiyah Gombong

RASIONALITAS PENGGUNAAN LONG-ACTING BETA AGONIST (LABA) KOMBINASI KORTIKOSTEROID DAN PERUBAHAN PARAMETER (FEV1) PASIEN PENYAKIT PARU OBSTRUKSI KRONIK (PPOK) RAWAT INAP RSUD Dr. SOEDIRMAN KEBUMEN 2024

MARLINDA ANGGARENI, NIM. 2021050064 (2025) RASIONALITAS PENGGUNAAN LONG-ACTING BETA AGONIST (LABA) KOMBINASI KORTIKOSTEROID DAN PERUBAHAN PARAMETER (FEV1) PASIEN PENYAKIT PARU OBSTRUKSI KRONIK (PPOK) RAWAT INAP RSUD Dr. SOEDIRMAN KEBUMEN 2024. Skripsi thesis, UNIVERSITAS MUHAMMADIYAH GOMBONG.

[img] Text
MARLINDA ANGGRAENI NIM. 2021050064.pdf

Download (1MB)

Abstract

Background, Chronic Obstructive Pulmonary Disease requires rational therapy. The combination of Long Acting Beta Agonist (LABA) and corticosteroids is considered rational if it meets the five rights (indication, drug, dose, interval, and route) and is evaluated through changes in FEV1 in hospitalized patients at RSUD Dr. Soedirman Kebumen. Objective, This study aims to evaluate the rationality of using a combination of Long Acting Beta Agonist (LABA) and corticosteroids, as well as to assess changes in clinical parameters (FEV1) in hospitalized COPD patients at RSUD Dr. Soedirman Kebumen. Method, This study uses a retrospective observational design with medical record data of hospitalized COPD patients at RSUD Dr. Soedirman Kebumen in 2024. Out of 124 patients, 88 met the inclusion criteria. Evaluation of drug rationality based on five parameters and clinical changes assessed through FEV1. Results, Out of the 88 patients studied, the majority were male (69.4%) and elderly (>65 years) (52.2%). The average evaluation of the rationality of drug use was recorded at (83.2%), with (16.8%) of patients being irrational. As many as 77 patients (87.5%) experienced an increase in FEV1, 4 patients (4.5%) had stable FEV1 values, and 7 patients (8%) experienced a decrease in FEV1 values, indicating a change from the combination of the medication. Conclusion, This study shows that the majority of hospitalized COPD patients at RSUD Dr. Soedirman Kebumen are male (69.4%). The rationality of using the combination of LABA and corticosteroids reached 83.2%, with 16.8% being irrational. As many as 87.5% of patients experienced an increase in FEV1, 4.5% remained the same, and 8% decreased, indicating the effectiveness of the therapy. Recommendation, It is expected that there will be an improvement in the accuracy of dosage and timing of administration, as well as regular evaluations based on national therapy guidelines to optimize the therapy.

Item Type: Thesis (Skripsi)
Additional Information: apt. Ayu Nissa Ainni, M.Farm; Dr. H. apt. Husnul Khuluq, M.Farm
Uncontrolled Keywords: COPD (Chronic Obstructive Pulmonary Disease); drug rationality; Long Acting Beta Agonist (LABA); corticosteroids; FEV1; PPOK (Penyakit Paru Obstruktif Kronis); rasionalitas obat
Subjects: S1 Farmasi
Divisions: Prodi Farmasi S1
Depositing User: Desy Setiyawati -
Date Deposited: 17 Nov 2026 05:44
Last Modified: 17 Nov 2026 05:44
URI: http://repository.unimugo.ac.id/id/eprint/4602

Actions (login required)

View Item View Item